Authors
Cristina Antinozzi, Luigi Di Luigi
Published in
Molecular biology reports. Volume 53. Issue 1. Oct 10, 2026. Epub Oct 10, 2026.
Abstract
The regeneration of skeletal muscle depends on the activation and differentiation of myogenic progenitor cells. Tadalafil, one of the phosphodiesterase type 5 inhibitors, is known to modulate nitric oxide/cGMP signaling; however, its prolonged effects on myogenic progression are not well understood. This study investigates the impact of prolonged tadalafil exposure on C2C12 myoblasts and early myogenic progenitor markers activation.
C2C12 cells were treated with 1 µM tadalafil for up to seven days, and analyzed for proliferation, viability, myogenesis activation and myokine release.
Prolonged tadalafil treatment significantly increased cell proliferation and survival, reducing cell death at all time points. Although tadalafil enhanced the expression of early myogenic factors, it simultaneously delayed terminal differentiation, reducing MHC-positive multinucleated myotubes, while maintaining higher expression levels of Pax7 and Myf6 after seven days, consistent with a less differentiated phenotype. This result was accompanied by the upregulation of Sirt3 and IL6, and the downregulation of myostatin and TGFβ.
Tadalafil promoted a highly proliferative state and preventing premature differentiation. These findings suggest its potential use as an adjuvant pharmacological therapy in the treatment of muscle-wasting disorders. However, the potent improvement of muscle regenerative machinery raises critical concerns regarding its potential misuse as a performance-enhancing drug in sport, highlighting the need for evaluation by anti-doping agencies.
PMID:
42859332
Bibliographic data and abstract were imported from PubMed on 11 Oct 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 16
- Comments 0